로딩 중…
StockDiggingStockDigging

원텍

336570· KOSDAQ
₩5,870-5.02%
2026-06-19

Price Chart

원텍-46.97%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap525.84B KRW
Revenue159.67B KRW
Net Income33.72B KRW
Total Assets227.28B KRW
Net Assets163.41B KRW
Employees228
Value
P/E15.59x
P/B3.22x
P/S3.29x
EV/EBITDA58.49x
FCF Yield9.50%
Profitability
ROE20.64%
ROA14.84%
Op. Margin30.27%
Revenue Growth7.57%
Earnings Growth-12.56%
Financial Health
Debt Ratio139.08%
Total Debt18.72B KRW
FCF49.94B KRW
Cash24.12B KRW
Current Ratio3.05x
Net Debt/EBITDA-0.61x
Dividend
Div. Yield0.81%
Div. Growth0.00%
Performance
1Y Return-46.97%
1M Return-20.14%
From 52W High-56.23%
1Y MDD-55.93%
Trading
Volume787,998 shares
Foreign Own.2.25%
Per Share
EPS375 KRW
BPS1,831 KRW

Company Info

CEO 김종원, 김정현
Employees 228
Founded 2019
HQ 대전광역시 유성구, KR

Established in 1999 as a specialized medical device company, Wontech is headquartered in Yuseong-gu, Daejeon Metropolitan City, having completed a merger with Daishin Balance No. 8 Special Purpose Acquisition Company in 2022. It primarily manufactures and sells skin aesthetics lasers and energy-based medical devices, including Oligio, Picocare, and Lavieen, actively exporting to Asia, Europe, the Middle East, and South America. The company diversifies its product lineup through RF and HIFU technology development and strengthens competitiveness by developing Monopolar RF Oligio.